These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35214070)

  • 61. Acceptability of different oral formulations in infants and preschool children.
    van Riet-Nales DA; de Neef BJ; Schobben AF; Ferreira JA; Egberts TC; Rademaker CM
    Arch Dis Child; 2013 Sep; 98(9):725-31. PubMed ID: 23853004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Formulation and Clinical Evaluation of Sodium Benzoate Oral Solution for the Treatment of Urea Cycle Disorders in Pediatric Patients.
    Maines E; Urru SAM; Burri E; Piccoli G; Pedrolli A; Pasqualini A; Burlina AL; Temporin G
    AAPS PharmSciTech; 2020 Mar; 21(3):100. PubMed ID: 32152836
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Past, Present, and Future of Oral Dosage Forms for Children.
    Meyers RS
    J Pediatr Pharmacol Ther; 2024; 29(1):22-31. PubMed ID: 38332958
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).
    Alessandrini E; Brako F; Scarpa M; Lupo M; Bonifazi D; Pignataro V; Cavallo M; Cullufe O; Enache C; Nafria B; Claverol J; De Taeye L; Vermeulen E; Preston J; Tuleu C
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063499
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population.
    Vallet T; Belissa E; Laribe-Caget S; Chevallier A; Chedhomme FX; Leglise P; Piccoli M; Michelon H; Bloch V; Meaume S; Grancher AS; Bachalat N; Boulaich I; Abdallah F; Rabus M; Rwabihama JP; Ribemont AC; Lachuer C; Perquy I; Lechowski L; Delahaye A; Depoisson M; Orven Y; Guinot C; Gibaud S; Michel C; Mahiou A; Belbachir SA; Trouvin JH; Dufaÿ-Wojcicki A; Boudy V; Ruiz F
    Pharm Res; 2018 May; 35(7):136. PubMed ID: 29736594
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
    Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
    Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Children's medicines in Tanzania: a national survey of administration practices and preferences.
    Adams LV; Craig SR; Mmbaga EJ; Naburi H; Lahey T; Nutt CT; Kisenge R; Noel GJ; Spielberg SP
    PLoS One; 2013; 8(3):e58303. PubMed ID: 23484012
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
    Liu F; Ghaffur A; Bains J; Hamdy S
    Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of intravenous ibuprofen and paracetamol in the treatment of fever: A randomized double-blind study.
    Can Ö; Kıyan GS; Yalçınlı S
    Am J Emerg Med; 2021 Aug; 46():102-106. PubMed ID: 33740568
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation.
    Rittig S; Baka-Ostrowska M; Tøndel C; Walle JV; Kjaeer B; Passier P; Bosman B; Stroosma O; Tannenbaum S
    J Pediatr Urol; 2020 Feb; 16(1):31.e1-31.e10. PubMed ID: 31787582
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Solid oral forms availability in children: a cost saving investigation.
    Lajoinie A; Henin E; Kassai B; Terry D
    Br J Clin Pharmacol; 2014 Nov; 78(5):1080-9. PubMed ID: 24965935
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Has the use of antipyretics been modified after the introduction of different concentrations of ibuprofen into the market?].
    García Blanes CP; Rodríguez-Cantón Pascual P; Morales-Carpi C; Morales-Olivas FJ
    An Pediatr (Barc); 2014 Dec; 81(6):383-8. PubMed ID: 24629903
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metamizole vs. ibuprofen at home after day case surgery: A double-blind randomised controlled noninferiority trial.
    Stessel B; Boon M; Pelckmans C; Joosten EA; Ory JP; Wyckmans W; Evers S; van Kuijk SMJ; Van de Velde M; Buhre WFFA
    Eur J Anaesthesiol; 2019 May; 36(5):351-359. PubMed ID: 30946703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patient-centred, administration friendly medicines for children - an evaluation of children's preferences and how they impact medication adherence.
    Bryson SP
    Int J Pharm; 2014 Aug; 469(2):257-9. PubMed ID: 24797763
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Open-label taste-testing study to evaluate the acceptability of both strawberry-flavored and orange-flavored amylmetacresol/2,4-dichlorobenzyl alcohol throat lozenges in healthy children.
    Thompson A; Reader S; Field E; Shephard A
    Drugs R D; 2013 Jun; 13(2):101-7. PubMed ID: 23588685
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.
    Venables R; Stirling H; Batchelor H; Marriott J
    Int J Clin Pharm; 2015 Dec; 37(6):1057-67. PubMed ID: 26173937
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characteristics of unintentional ingestion of oral non-steroidal anti-inflammatory drugs and analgesics in preschool children.
    Babić Ž; Kordić NB; Rešić A; Turk R
    Arh Hig Rada Toksikol; 2021 Dec; 72(4):299-304. PubMed ID: 34985841
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prescribing, dispensing and administration indicators to describe rational use of oral dosage forms of medicines given to children.
    Nadeshkumar A; Sathiadas G; Pathmeswaran A; Ranganathan SS
    WHO South East Asia J Public Health; 2019 Apr; 8(1):42-49. PubMed ID: 30950430
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Formulation factors affecting acceptability of oral medicines in children.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Kendall R; Tuleu C;
    Int J Pharm; 2015 Aug; 492(1-2):341-3. PubMed ID: 25959115
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.